Pregnancy: Antiphospholipid antibodies and human reproductive failure

Routine screening for circulating antiphospholipid antibodies(aPL), namely the lupus anticoagulant (LA) and anticardiolipinantibodies (aCL), was carried out in a total of 1273 women aged<45 years. Of them, 822 were experimental subjects and 451were controls. The former comprised the following three studygroups: 498 infertile patients (group 1), 284 spontaneous recurrentaborters (group 2), and 40 patients with repeated failure ofembryo transfer (group 3). Controls included five groups ofwomen: 125 normal healthy women who had never been pregnant(group 4), 125 normal healthy parous women with no previousabortion (group 5), 52 women in labour after normal pregnanciesat term (group 6), 49 infertile patients achieving a livebirthwith their first in-vitro fertilization (IVF) and embryo transfer(group 7), and 100 female patients with systemic lupus erythematosus(positive controls, group 8). aPL positivity in the eight groupsstudied was as follows: 2.4, 9.2, 10, 0.8, 0, 0, 0 and 42% respectivelyfor groups 1 to 8. There were no differences within groups 1and 3 regarding incidence of aPL when patients were groupedaccording to infertility aetiological factors and indicationsfor IVF respectively. Twenty-six out of 284 recurrent aborters(9.2%) tested positive for aPL, and the LA and/or aCL were identifiedas the aetiological factor in 12% of patients (24/199) withsupposedly unexplained recurrent abortion. Incidence of positivesera for aPL in group 1 was similar to that observed in controlgroups 4, 5 and 6. On the contrary, incidence of aPL positivityin groups 2 and 3 was significantly higher than in control groups4, 5 and 6 and among infertile women (group 1). The differencebetween groups 3 and 7 almost reached statistical significance.Interestingly, there was no difference between groups 2 and3, but groups 2 and 7 resulted probably different regardingincidence of aPL positive sera. As expected, the highest incidenceof patients testing positive for aPL was found in group 8. Seveninfertile patients having circulating aPL and becoming pregnantspontaneously or after specific infertility treatment, successfullycarried to term in spite of the fact that they did not receiveimmunotherapy. Among recurrent aborters, the live-born babyrate was significantly higher after treatment with low-doseaspirin than prior therapy. It is concluded that the presenceof circulating aPL may be associated with recurrent abortionbut not with infertility. In addition, our results favour apossible role of aPL hi failure of implantation after IVF andembryo transfer.